VanEck Biotech ETF (BBH) Stock Price & Analysis
VanEck Biotech ETF (BBH) closed at USD 246.57 on Friday, October 23, 2026, down 0.38% on the day. The US market is currently closed; this is not a live price.
The prior close was USD 247.51; the Oct 23, 2026 session ranged USD 246.05–247.69 on volume of 4,467 shares. Market capitalization is —, with a 52-week range of USD 176.3–251.45 (NGM). Source: Nexqual, retrieved October 24, 2026 at 14:10 UTC.
Also available as compact Markdown for AI agents: nexqual.com/BBH.md
Key facts (BBH)
- Total return with dividends: 1Y +39.6% vs S&P 500 +13.4%; 5Y +26.6% vs S&P 500 +76.9%.
Total return (dividends reinvested) (BBH)
| 1Y (from 2025-10-24) | 5Y (from 2021-10-25) | |
|---|---|---|
| Total return | +39.6% | +26.6% |
| S&P 500 (SPY) | +13.4% | +76.9% |
| Per year | +39.8% | +4.8% |
| Volatility (annualized) | 22.3% | 21.6% |
| Max drawdown | -10.6% (Jan 2026→May 2026) | -31.3% (Oct 2021→Jun 2022) |
BBH options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 27 | 26.9% | ±6.0% |
| Dec 18, 2026 | 55 | 25.3% | ±7.9% |
| Mar 19, 2027 | 146 | 25.0% | ±12.7% |
| Jun 17, 2027 | 236 | 24.8% | ±16.0% |
30-day implied volatility 26.1% vs 23.7% realized over the last 30 trading days. Put/call ratio (volume) 0. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 24, 2026 at 14:10 UTC)
| Price | USD 246.57 |
|---|---|
| Change | ▼ 0.38% (down) |
| Previous Close | USD 247.51 |
| Open | USD 247.53 |
| Day Range | USD 246.05 – 247.69 |
| 52-Week Range | USD 176.3 – 251.45 |
| Volume | 4,467 shares |
| Market Cap | — |
| Exchange | NGM |
Technical Analysis (BBH)
Nexqual's technical model rates BBH "STRONG BUY" based on 5 bullish and 0 bearish signals across 127 daily candles, as of October 24, 2026 at 14:10 UTC.
| Overall Signal | STRONG BUY |
|---|---|
| RSI (14) | 57.56 (neutral) |
| vs SMA50 | Above (USD 238.64) |
| MACD | 3.01 (positive) |
Financial Health Score (BBH)
Nexqual rates VanEck Biotech ETF's overall financial health "Mixed" across five dimensions, as of October 24, 2026 at 14:10 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Mixed — No data |
| Balance Sheet | Mixed — No data |
| Cash Flow | Mixed — No data |
| Efficiency | Mixed — No data |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PPH | VanEck Pharmaceutical ETF | USD 114.93 | ▼ 1.8% |
| HHH | Howard Hughes Holdings Inc. | USD 70.19 | ▲ 1.01% |
| RTH | VanEck Retail ETF | USD 267.89 | ▼ 1.72% |
| FBT | First Trust Amex Biotech Index | USD 269.25 | ▼ 1.26% |
| PBE | Invesco Biotechnology & Genome | USD 98.72 | ▼ 0.67% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 24, 2026 at 14:10 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt